跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,771 条关于
“Curium Group”
全部
26,771
临床试验
18,130
药物
580
机构
532
资讯
7,529
11个月前
PeptiDream, PDRadiopharma and Curium Initiate Registrational Trial for 64Cu-PSMA-I&T in Japanese Prostate Cancer Patients
3个月前
Curium, PeptiDream and PDRadiopharma Complete Patient Dosing in Phase 2 Trial of 64Cu-PSMA-I&T PET Diagnostic for Prostate Cancer in Japan
去年
Curium Expands European Nuclear Medicine Footprint with Strategic Acquisitions of Nucleis and Monrol
4个月前
Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight
去年
Curium Completes Enrollment of Phase 3 SOLAR-RECUR Prostate Cancer Trial
3个月前
Delaware Court Clears Path for Curium's Lutetium Lu 177 Dotatate in GEP-NETs, Invalidating Novartis Patents
前天
FDA Approves Bexlutry, First Generic Radioligand Therapy, After Curium Wins Novartis Patent Dispute
去年
Curium and PDRadiopharma Collaborate to Advance PSMA-Targeting Theranostics in Japan
8个月前
Curium Receives Chinese Regulatory Approval to Begin Phase 3 Trial of 177Lu-PSMA-I&T for Metastatic Prostate Cancer
前天
FDA Approves Curium's Bexlutry, First Generic Radioligand, Challenging Lutathera's GEP-NET Monopoly
第 1 页,共 753 页
上一页
下一页